A Single Dose Study of E6130 in Japanese Healthy Adult Male Subjects

NCT02902978 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
56
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

EA Pharma Co., Ltd.